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Abstract
New perspectives have been opened by advances in stem cell research for
reproductive and regenerative medicine. Several different cell types can be
differentiated from stem cells (SCs) under suitable in vitro and in vivo conditions.
The differentiation of SCs into male germ cells has been reported by many groups.
Due to their unlimited pluripotency and self‐renewal, embryonic stem cells (ESCs)
and induced pluripotent stem cells (iPSCs) can be used as valuable tools for drug
delivery, disease modeling, developmental studies, and cell‐based therapies in
regenerative medicine. The unique features of SCs are controlled by a dynamic
interplay between extrinsic signaling pathways, and regulations at epigenetic,
transcriptional and posttranscriptional levels. In recent years, significant progress
has been made toward better understanding of the functions and expression of
specific microRNAs (miRNAs) in the maintenance of SC pluripotency. miRNAs are
short noncoding molecules, which play a functional role in the regulation of gene
expression. In addition, the important regulatory role of miRNAs in differentiation
and dedifferentiation has been recently demonstrated. A balance between
differentiation and pluripotency is maintained by miRNAs in the embryo and stem
cells. This review summarizes the recent findings about the role of miRNAs in the
regulation of self‐renewal and pluripotency of iPSCs and ESCs, as well as their impact
on cellular reprogramming and stem cell differentiation into male germ cells.
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1 | INTRODUCTION
Germ cells are able to transfer genetic information to offspring in
sexually reproductive species, such as mammals. The emerge of
pluripotent stem cells in biology is considered as a breakthrough,
which resulted in a new field of science known as regenerative
medicine (Medrano, Pera, & Simon, 2013). One of the fields of
research, which has had considerable effects in this regard, is
regenerative medicine. All forms of cell therapy, including induced
pluripotent stem cells (iPSCs) and embryonic stem cells (ESCs), have
played a significant role in some fields of medicine (Bianconi et al.,
2018; Hirschi, Li, & Roy, 2014).
The most significant abilities of stem cells include self‐renewal
and differentiation. Currently, the main sources of stem cells to
differentiate into male germ cells are the ESCs, the iPSCs, and
spermatogonial stem cells (SSCs; Hou et al., 2014). Scientists have
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recently established the iPSCs cells from somatic cells in a break-
through by overexpressing some transcription factors, including
c‐Myc, Klf4, Sox2, and Oct4 (Woltjen et al., 2009). Despite the ability
of iPSCs to act as sperm cells and express functional genes, there are
some safety challenges in their application, which seem more
propitious to generate a safe and effective solution for infertility in
men (Zhang et al., 2014). Several studies have shown the
differentiation ability of ESCs into germ cells in vitro (Jung
et al., 2017).
Intercellular and intracellular mechanisms control self‐renewing
divisions of stem cells (Judson, Babiarz, Venere, & Blelloch, 2009).
Differential gene expression is regulated by intracellular mechanisms
at epigenetic, transcriptional, translational, and posttranslational
levels, whereas the neighboring niche cell signaling is controlled by
intercellular mechanisms (Kim et al., 2012). iPSCs have been reported
to be fairly similar to their embryonic counterparts. However, it has
been suggested by an study of gene expression profiles of human
iPSCs (hiPSCs), mouse iPSCs (miPSCs), mouse ESCs (mESCs) and
human ESCs (hESCs) that, regardless of the generation method or the
origin, a recurrent signature of gene expression appears in iPSCs (Xu,
Papagiannakopoulos, Pan, Thomson, & Kosik, 2009). The similarity of
hiPSCs’ and hESCs’ gene‐expression profiles increases when the
culture is extended; however, there is still a unique signature of gene
expression that is different from iPSCs and hESCs, extending to
microRNA (miRNA) expression (Jia, Chen, & Kang, 2013). The iPSCs
signature gene expression differences have been suggested by
genome‐wide data to be the result of a mechanism, in which the
reprogramming factors differentially bind to promoter sequences
(Chin et al., 2009).
Noncoding RNAs (ncRNAs) are required to establish the pluripotent
network in cell reprogramming. They are also relatively essential for
somatic cell reprogramming into pluripotency (Luginbühl, Sivaraman, &
Shin, 2017). Long noncoding RNAs (lncRNAs) and miRNAs have
recently emerged as important factors, which play critical roles in
translational regulation and controlling stem cell behavior and fate
(Gangaraju & Lin, 2009).
miRNAs, with the range of 18–23 bp, are considered as
significant regulators in gene silencing at transcriptional and
posttranscriptional levels in many organisms (Hayashi et al., 2008).
miRNAs are able to regulate genetic controlling of differentiation
and pluripotency of ESCs and reprogramming of iPSCs (Clancy
et al., 2014). They are well‐characterized as important elements
with the ability of regulating differentiation and development. It
has been demonstrated that specific miRNAs are highly expressed
in iPSCs and ESCs to control the expression of pluripotency‐
related genes (Miyoshi et al., 2011). In somatic stem cells and ESCs
of vertebrates, the critical role of miRNAs pathway has been
reported in maintenance of germ line stem cells. Moreover, their
roles have been demonstrated in the maintenance of germ line
stem cells and specification of primordial germ cells (PGCs) in
invertebrates (Gangaraju & Lin, 2009). Furthermore, miRNAs are
quite essential for spermatogenesis and may play a vital role
during stages of mitosis, meiosis, and post‐meiotic of germ cells
and spermatogenesis by regulating the target gene expression
(Wang & Xu, 2015).
Therefore, the present study aimed to study the current rapidly
expanding state of understanding of miRNA roles in regulation of
embryonic and induced pluripotent states into male germ cells.
2 | STEM CELLS
Generally, stem cells are characterized as cells with division ability
for an unlimited period of time throughout an individual's life (self‐
renewal; Mahabadi, Sabzalipour, Bafrani, Gheibi Hayat, & Nikzad,
2018; Wilson et al., 2009). They can differentiate into several various
lineages, with specialized functions and different properties, under
specific signals and appropriate differentiation conditions (Jaenisch &
Young, 2008). In addition, these undifferentiated cells are able to
either differentiate into specialized cells or self‐renew. Due to their
unique properties, stem cells are highly qualified for both biomedical
and basic research in cell biology (Hu & Shan, 2016). Stem cells are
classified into five groups of unipotent, oligopotent, multipotent,
totipotent, and pluripotent based on their potential of differentiation
(Zomer, Vidane, Goncalves, & Ambrosio, 2015).
3 | PLURIPOTENT STEM CELLS
Pluripotency is the potential of a cell in developing into all various
cell types. This potential is found in an adult and embryonic organism,
with the exception of extraembryonic organs, such as umbilical cord
and placenta (Robinton & Daley, 2012). Both of these unique
properties make pluripotent stem cells attractive sources for
regenerative medicine and cell‐based therapies (Luginbühl et al.,
2017; Tabar & Studer, 2014). However, there are still some
unresolved technical problems in the area of cell therapy, such as
the best method for manipulation of cells, best delivery system of
cells and best source of cells (Bianconi et al., 2017). Pluripotent stem
cells are characterized in five types, including ESCs, embryonic
carcinoma cells, embryonic germ cells, testis derived germ line stem
cells, and iPSCs.
3.1 | Embryonic stem cells
According to the literature, ESCs are derived from the inner cell mass
of mouse or human blastocysts, possessing the remarkable capacity
of differentiation into the cells of all three germ layers as well as male
and female germ cells (Qing et al., 2007). Recently, it has been
reported that mESCs have the ability to produce sperm‐like cells and
PGCs in vitro (Pelosi, Forabosco, & Schlessinger, 2011). It is believed
that the ability of germ cells production from mESCs present a
powerful in vitro model, aiming to study the development of germ
cells and to offer new infertility treatment approaches (Miryounesi,
Nayernia, Dianatpour, & Mansouri, 2013; Silva et al., 2009; Zhou,
Meng, & Li, 2010). To produce hESCs, serum containing medium and
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fibroblast feeders were used, whereas differentiation in hESCs was
caused by bone morphogenetic protein (BMP) and LIF, both of which
support mESCs self‐renewal. In contrast to mESCs, activin, TGF‐β,
and bFGF are the main factors needed for hESCs self‐renewal
(Greber, Lehrach, & Adjaye, 2007; Nii et al., 2014). However, there
are some ethical limitations against the research on use of human
embryos. Moreover, the tissue rejection in the recipient is a serious
problem.
3.2 | Induced pluripotent stem cells
Any tissue of the body can be used to induce pluripotent stem cells
by employing a mixture of reprogramming factors (Takahashi &
Yamanaka, 2006). It has been reported that iPSCs or pluripotent
ESCs of human, monkey, and rodent are able to differentiate into
germ cells (Easley et al., 2012; Kee, Angeles, Flores, Nguyen, & Pera,
2009; Park et al., 2009). More important, the production of germ cell
replacement with the patients’ own somatic cells will alleviate some
problems associated with using current method to treat infertility
(Teramura & Frampton, 2013). Differentiation of embryonic stem
cells or induction of pluripotent stem cells into epiblast‐like cells is
possible to increase primordial germ cell‐like cells if they are being
cultured in the media with BMP‐4 (Hayashi, Ohta, Kurimoto,
Aramaki, & Saitou, 2011). However, the technology of the iPSC
differentiation into germ cell is well developed for the human clinical
applications (Gassei & Orwig, 2016; Figure 1).
3.3 | In vitro differentiation of PGCS towards a
spermatogenic cell fate
Some coordinated steps are needed for the early gametogenesis
process, including specification of PGC, movement to and coloniza-
tion of the gonadal ridges, followed by differentiation into more
mature gametes (Linher, Dyce, & Li, 2009). Currently, researchers
have demonstrated the differentiation capability of ESCs into
gametes (Geijsen et al., 2004; Hubner et al., 2003; Kerkis et al.,
2007; Lacham‐Kaplan, Chy, & Trounson, 2006; Linher et al., 2009;
Nayernia et al., 2006; Novak et al., 2006; Qing et al., 2007; Toyooka,
Tsunekawa, Akasu, & Noce, 2003). Several studies have used murine
ESCs differentiation into embryoid bodies (EBs), the ability of which
to generate putative PGC‐like cells was approved later (Geijsen et al.,
2004; Toyooka et al., 2003; J. A. West, Park, Daley, & Geijsen, 2006).
The gametogenesis process from the PGCs formation to func-
tional gametes has not been wholly recreated in vitro in any species
of mammalian. Currently, the most possible methods to generate
functional oocytes or sperm from PGCs are based on in vitro
transplantation of tissues, which contain PGCs, from embryos or
after PGCs being reaggregated in vitro with somatic cells of gonads
into the gonads of prepuberal/adult hosts (Ge, Chen, De Felici, &
Shen, 2015).
ESCs are involved in many fundamental studies on pluripotency
and differentiation to germ cells. The differentiation capability of
mESCs into PGC‐like cells, which are able to be engrafted into testis
and to form sperm, has been reported as well (Toyooka et al., 2003).
PGCs and haploid cells have been reported to emerge from hESCs
(Aflatoonian & Moore, 2006). While spontaneous differentiation of
pluripotent stem cells was the basis of the mentioned studies, the
gonadal microenvironment and signaling molecules can strongly
affect germ cell differentiation (Li et al., 2014).
Recently, germ cells production from iPSCs has been demon-
strated by several reports. For the first time, PGC‐like cells
production was shown by coculture with fetal gonads of human
(Park et al., 2009). Supplementation of BMP4 enhances the
differentiation of hiPSCs to VASA‐GFP‐positive PGC‐like cells
(Eguizabal et al., 2011).
4 | DIFFERENTIATION OF GERM CELLS
USING IPSCS AND ESCS
Cocultures containing embryonic fibroblasts increase differentiation
of pluripotent cells into PGCs (Park et al., 2009) and sertoli cells
(Geens, Sermon, Van de Velde, & Tournaye, 2011; F. D. West et al.,
2008), which in response increase the differentiation of pluripotent
stem cells to PGCs. Although desired results may be obtained using
these coculture systems, biologically or chemically defined factors
F IGURE 1 To generate induced pluripotent stem cells (iPSCs), retroviruses encoding four factors of pluripotency (OCT4, c‐MYC, KLF4, and
SOX2) are used to transduce adult somatic cells. Fully reprogrammed iPSCs were selected and spread and can be used in human disease models,
cell therapy, and drug screening. The own cells of patient are capable to be used to derive iPSCs, of which several kinds of somatic cells with
the same genetic information as the patient can be differentiated [Color figure can be viewed at wileyonlinelibrary.com]
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are preferred for induction due to their ability to improve the cells’
safety for clinical application and enhance the reproducibility of
differentiation procedure. Therefore, application of defined media
with growth factors is considered as a standard option for
differentiation induction (Amini Mahabadi et al., 2018). In this
respect, BMP8b and BMP4 promote the ESCs differentiation into
PGC‐like cells (Hiller, Liu, Blumenthal, Gearhart, & Kerr, 2010), and
retinoic acid (RA) can be used for meiosis stimulation (Eguizabal et al.,
2011). Furthermore, cytokines such as forskolin, leukemia inhibitory
factor (LIF), and SCF increase germ line differentiation from
pluripotent stem cells by enhancing in vitro self‐renewal of SSCs
named GDNF (Eguizabal et al., 2011; F. D. West et al., 2010), and
adenylate cyclase activator. In addition, manipulations may occur in
gene expression to control lineage specification of differentiating
pluripotent stem cells. In this respect, it could be stated that
overexpression of VASA and DAZL promotes PGCs to be formed
from hESCs, whereas the overexpression of BOULE and DAZ
promotes the development of the haploid germ (Kee et al., 2009).
When haploid cells are induced by culturing the iPSC‐derived PGCs
in bFGF, forskolin, LIF, and an inhibitor of CYP26 (a P450 enzyme),
and all‐trans RA can be inactivated (Eguizabal et al., 2011). The rate
of meiotic cell formation was improved by Medrano et al. through
employing plasmids to induce DAZ and VASA overexpression in
hiPSCs (Medrano, Ramathal, Nguyen, Simon, & Reijo Pera, 2012).
Molecular mechanisms for the development of primate germline
cells and functional assays in vivo which can be extrapolated for the
differentiation of human germ cell will be revealed by further studies
(Teramura & Frampton, 2013; Figure 2). It has been demonstrated
that ncRNAs play the regulatory role in stem cells. Primary
explorations have discovered small ncRNAs, such as miRNA, Piwi‐
interacting RNA (piRNA), and small interfering RNA (siRNAs) in stem
cells, all of which have been reported to play a regulatory role in
processes such as male germ cell development. Nonetheless, further
research is required to determine the precise function of ncRNAs in
the development of male germ cells (Lee, Xiao, & Rennert, 2012).
5 | NONCODING RNA DEFINITION
Non‐encoding RNAs (noncoding RNAs) can be characterized into two
groups of regulatory noncoding RNAs and housekeeping noncoding
RNAs. With a regulatory role, RNA is mainly divided into two types
based on size: long noncoding RNA (lncRNAs) and short noncoding
RNAs (e.g., miRNAs, siRNAs, and piRNAs; Wei, Huang, Yang, &
Kang, 2017).
Considered as major players in defining a cell's identity, ncRNA
molecules were previously thought to exert only passive roles.
Alongside with the coding portion of the genome, the correlation of
noncoding counterpart with the greater complexity of higher
eukaryote is now clear (Mattick, 2011). Recently, ncRNAs have been
characterized as new regulatory factors in gene expression profile of
pluripotent cells. Among small noncoding RNAs with the size of less
than 200 nucleotides, miRNAs are now recognized as the major
regulators of metabolism, development, homeostasis, and differentia-
tion in all multicellular organisms (Rosa & Brivanlou, 2013; Rottiers &
Näär, 2012).
Currently, the involvement of miRNAs in developmental pro-
cesses (e.g., development of human preimplantation development)
has been confirmed. In addition, they have been recognized as
considerable adjusting molecules for dedifferentiation and differ-
entiation of cells (Kedde & Agami, 2008). In addition, it seems
that dissemination and progression of various types of cancer
(e.g., ovarian cancer) are greatly affected by the dysregulation of
miRNA expression (e.g., modulation miRNAs).
F IGURE 2 The sources of cells, from which spermatogonia stem cells can be derived. (a) The isolation of pluripotent inner mass cells are
obtained from donated fertilization embryos which are at the blastocyst stage, followed by indefinite expansion in culture as human embryonic
stem cells (hESCs). (b) As an alternative way, patient‐specific induced pluripotent stem cells (iPSCs) are able to be reprogrammed from
somatic cells, such as fibroblasts, by transduction using a cocktail of embryonic transcription factors (sex‐determining region Y‐box 2 [Sox2],
octamer‐binding transcription factor 4 [Oct4], c‐Myc, and Kruppel‐like factor 4 [Klf4]) [Color figure can be viewed at wileyonlinelibrary.com]
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miRNAs, together with exosomes, have a great potential to be
used for prognosis, therapy, and biomarkers of different diseases,
including infertility. miRNAs may play an important role in modulat-
ing gene expression during human preimplantation development
from primordial germ cells to the embryo (Virant‐Klun, Stahlberg,
Kubista, & Skutella, 2016).
Some of the previously recognized roles of miRNAs have been
observed in impaired endometrial receptivity, altered embryo devel-
opment, implantation failure after ART, and in ectopic pregnancy and
pregnancies of unknown location (Galliano & Pellicer, 2014).
miRNAs play critical roles in reprogramming process, pluripo-
tency maintenance, and differentiation of stem cells. Moreover,
the significant function of miRNAs in the determination of stem
cell fate indicates the way miRNAs regulate mammalian develop-
ment in vivo (Li, Long, Han, Yuan, & Wang, 2017). During
spermatogenesis, miRNAs are expressed in a cell‐specific or
stage‐specific manner. Nonetheless, the underlying mechanisms
and roles of most of the miRNAs in spermatogenesis are still not
clear. In the end, particular miRNAs in seminal plasma or
spermatozoa will be applied as possible biomarkers for infertility
of men. Etiology of male infertility and sterility becomes more
clear with the explanation of the miRNAs and the clarification of
their adjusting mechanisms (Chen, Li, Guo, Zhang, & Zeng, 2017).
As a result, particular miRNAs have been used as possible
biomarkers for infertility of men (Yadav & Kotaja, 2014).
To perform hepatitis C‐related human clinical trials and nonhuman
primate preclinical trials, researchers have tested some of the most
developed anti‐miR therapies (e.g., micro‐RNA modulation) to assess
their efficiency (Beavers, Nelson, & Duvall, 2015). There are two
possible categories of the miRNA therapy, including miRNA inhibition
and replacement therapies with the ability of downregulating and
upregulating the expression of the miRNA, respectively. However, this
classification depends of the expression status of the target miRNA
(Peng, Chen, & Leong, 2015).
5.1 | The role of miRNAs in promoting epigenetic
modifications for reprogramming
Various small molecules and specific miRNAs and several different small
molecules were used to improve the efficiency of reprogramming
(Subramanyam et al., 2011). It has been suggested that the pathway of
miRNA play a critical role in both germline stem cell maintenance and
PGC specification in invertebrates (Gangaraju & Lin, 2009).
A number of miRNAs, including miR‐291‐3p, miR‐294, and
miR‐295, belongs to the cluster of miR‐290, which has been reported
to be able to increase the colony number of iPSCs and ESCs (Judson
et al., 2009). Another study has demonstrated the importance of
miRNAs in reprogramming, in which fibroblasts that lack all mature
miRNAs could not generate iPSCs (Kim et al., 2012). Therefore,
miRNAs are characterized as necessary factors for not only proper
differentiation but also dedifferentiation of fibroblasts (Luningschror,
Hauser, Kaltschmidt, & Kaltschmidt, 2013).
miRNAs have been demonstrated to regulate several genes
implicated in pluripotency, which are required for specification of
germ cells. miR‐145, for example, is able to suppress OCT4
expression, and partially repress SOX2 expression in ESCs of
human, resulting in promotion of their differentiation (Xu et al.,
2009). In addition, miR‐134, ‐296, and ‐470 play an important role
in regulation of SOX2, NANOG, and OCT4 in ESCs. The pluripotency
markers SOX2, NANOG, and OCT4 find promoters of miRNAs and
bind directly to them. For example, OCT4 binds to promoter of
miR‐302 cluster, which is specific for ESCs. This collaboration
between these molecules leads to the regulation of cell fate
F IGURE 3 The role of microRNAs (miRs) in pluripotent stem cell differentiation [Color figure can be viewed at wileyonlinelibrary.com]
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(McIver, Roman, Nixon, & McLaughlin, 2012; Rosa & Brivanlou,
2011; Figure 3).
5.2 | Are hESCs and hiPSCs more similar in their
noncoding RNA expression?
Most cell types are suggested to express a unique sequence of
ncRNAs including miRNAs (Signal, Gloss, & Dinger, 2016). It has been
reported that miRNAs suppress their homologous target RNAs from
expression by associating in a complex known as RISC (RNA‐induced
silencing complex; Pelosi et al., 2011). The pattern of miRNA
expression changes alongside with individual cells differentiation
and tissue development (Yi et al., 2009). Vast differences in
expression have been demonstrated by assessing miRNA expression
profiles of undifferentiated hiPSCs, hESCs, and fibroblasts, including
more than 100 miRNAs between these two fibroblasts and
pluripotent populations (Table 1; Chin et al., 2009).
A few number of miRNAs is expressed in different profiles in
hiPSCs and hESCs. In an independent study, it was concluded that
most of these miRNAs were expressed differentially between
independently derived hiPSCs and hESCs (Wilson et al., 2009).
Because each of these miRNAs have been shown to have multiple
targets, there is a possibility that even about 11 of them could reveal
the reason behind the occurrence of late hiPSCs signature (Chin
et al., 2009).
In addition, two sequences of miR‐371/372/373 and miR‐302
encoding the human homologs of the mouse 290–295 cluster have
been shown to be the enhancers of the reprogramming process
(Judson et al., 2009). Clearly, more investigations are required to
clarify the role of these and other ncRNAs in the ESCs and iPSCs
state maintenance and the reprogramming process.
5.3 | The effect of miRNA in male germ cell
development
Use of miRNAs in the development of germ cells has been
functionally demonstrated (Fernandez‐Perez, Brieno‐Enriquez, Iso-
ler‐Alcaraz, Larriba, & Del Mazo, 2018). The repression of the miRNA
Let7 is considered the best characterized pathway in germ cells of
mammalian, which is mediated by the RNA‐binding protein Lin28 to
send translation permission to Blimp1 during the first stages of
determining mouse germ cells (J. A. West et al., 2009). Furthermore,
the reciprocal regulation pathway of Let7 and Lin28 extends its role
to spermatogenesis (later stages) as regulators of pluripotency are in
conjugation with miR‐9 and miR‐125a (Zhong et al., 2010). Moreover,
miR‐125 plays a critical role in post transcriptional repression of
Oct4 during the stages of male meiotic silencing (Medrano
et al., 2013).
Altogether, miRNAs are mostly required to regulate the develop-
ment of male germ cells, which occurs in rodents, includes mitosis,
meiosis, and spermatogenesis (Saito et al., 2015) (Table 2). However,
more experiments must be conducted to show which miRNAs are
involved in spermatogenesis, in particular its three main stages in
human, pachytene spermatocytes, spermatogonia and round sperma-
tids (Liu et al., 2015). In addition, miRNAs have a significant effect on
meiotic and post‐meiotic cells. The expression of miR‐34c is
upregulated in spermatocytes, and apoptosis is triggered by round
spermatids (Romero et al., 2011). One mechanism that can partially
mediate this process is when transcription factor ATF‐1 is targeted.
Therefore, miR‐34c is essential for the development of germ cells.
Moreover, it has been shown that miR‐469 targets protamine and
transition protein 2 (TP2) mRNAs to be repressed in round spermatids
and pachytene spermatocytes (Dai et al., 2011). In addition, the
degradation of TP2 mRNA cleavage is controlled by miR‐122a, and
the mRNA of heat shock factor 2 can be directly targeted by miR‐18 at
the spermatogenesis stage (Chen et al., 2017). miR‐221/222 are also
required in the regulation of spermatogonia undifferentiated state
(Q.‐E Yang, Racicot, Kaucher, Oatley, & Oatley, 2013).
5.4 | The effect of miRNA in iPSCs and ESCs into
male germ cell differentiation
High levels of miR‐372 are expressed by iPSC and hESCs‐derived
primordial germ cell‐like cells (PGCLCs). Conversely, high levels of
let‐7 are expressed by somatic cells (Melton, Judson, & Blelloch,
2010). It has been demonstrated that when the levels of miRNA
are manipulated by knockdown with miRNA sponges or introduc-
tion of miRNA mimics, let‐7 antagonizes while miR‐372 promotes
differentiation. PGCLC production increases by knockdown of the
individual miR‐372 targets, including MECP2, SMARCC1, RBL2,
CDKN1, TGFBR2, and RHOC, whereas differentiation of PGCLC is
suppressed by knockdown of the let‐7 targets, including NMYC
TABLE 1 miRNA expressed differentially between hESCs and
hiPSCs from Wilson et al. (2009) and Chin et al. (2009)
Genes hESCs hiPSCs
hESCs/
hiPSCs Fibr. p value
miR‐371‐5p 626 162.5 3.85 7.7 0.0000713
miR‐373 287.9 106.7 2.70 70.3 0.0008055
miR‐421 249.8 139.6 1.79 4.2 0.0067477
miR‐346 328.3 204.5 1.61 37.1 0.0017787
miR‐302b 373.2 249.7 1.49 5.2 0.0046398
miR‐302a 2796.2 1889.5 1.48 3.6 0.0011021
miR‐136 109.1 159.6 0.68 4.0 0.0076601
miR‐565 3698.3 5481 0.67 6582.4 0.0040080
miR‐24 227.1 394 0.58 1946.7 0.0007480
miR‐199b‐3p 4.5 176.3 0.57 3066.2 0.0020272
miR‐181a 116.7 238.1 0.49 773.5 0.0005089
miR‐23b 488.1 1029 0.47 6856.4 0.0001696
miR‐23a 475.5 1108.1 0.43 7769.4 0.0007269
miR‐100 18.5 239.6 0.42 3198.4 0.0000101
miR‐125b 4.9 257.5 0.39 3498.9 0.0000002
miR‐214 149.2 394.8 0.38 1449.1 0.0000050
Note. hESCs: human embryonic stem cells; hiPSCs: human induced
pluripotent stem cells.
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and CMYC. These findings discovered that a miR‐372/let‐7 axis
plays a critical role to regulate the specification of PGC (Tran
et al., 2016).
it has also been reported that cluster of miR‐290–295 plays a role
in ESCs where it is a direct target of the Sox2, Nanog, and Oct4
regulatory network (Marson et al., 2008). During the development of
germ cells, spermatogonia and PGCs highly express the cluster
of miR‐17–92, which is reported to increase cell cycling, and the
ESCs‐specific cluster of miR‐290–295.
There is a correlation between the cluster of miR‐290 and
potency of development, the expression of miR‐290–295 decreases
following the differentiation of ESCs into germ cells. In addition, a
few members of the miR‐290 cluster have been reported to be able
to 10 folds enhance the reprogramming efficiency by Sox2, Oct4, and
Klf4 (Judson et al., 2009). Moreover, members of this cluster can
promote the transition of G1‐S and thereby the rapid ESCs
proliferation characteristics (Wang et al., 2008). Furthermore, it has
been shown that the miR‐290 cluster is involved in indirect control of
de novo DNA methylation in ESCs (Medeiros et al., 2011).
Although the first miRNAs upregulated in the embryo develop-
ment are the cluster of miR‐290, there is no need for this cluster in
ESC pluripotency or preimplantation development. Instead, lack of
miR‐290–295 had a great impact between midgestation and
implantation and during the development of germ cells. Approxi-
mately three‐quarters of deficient embryos lacking of miR‐290–295
were lost during the development of embryos (Medeiros et al., 2011).
5.5 | The effect of miRNAs in iPSC and ESCs
formation
Introduction of miR‐290 has strongly improved the formation of
iPSC, while no effect has been observed using other members of the
TABLE 2 miRNAs that have a role in regulation of spermatogenesis and spermatocyte meiosis
miRNAs Expression References Function
miR‐449 Localized to spermatids and spermatocytes Buchold et al. (2010) Prohibits proliferation of a germ cell line
miR‐34b Upregulation in testis Vogt et al. (2011), Yu
et al. (2014)
Regulates the germ cell proliferation
and survival
miR‐34a Upregulation in mouse testis at Day 7–14 Saito et al. (2015) Represses proliferation, promotes
apoptosis
miR‐34c Highly expressed in pachytene spermatocytes and round
spermatids
(Saito et al. (2015), Wu
et al. (2011)
Cycle regulator
mGSC apoptosis
SSC differentiation
miR‐184 Localized in mouse testis germ cells Liu et al. (2013), McIver
et al. (2012)
Induces the germ cell line proliferation
miR‐24 Pachytene spermatocytes Liu et al. (2013) Meiosis
miR‐214 Pachytene spermatocytes Liu et al. (2013), Liu
et al., 2015)
Meiosis
miR‐320 All germ cells Liu et al. (2013), Liu
et al. (2015)
Cell adhesion
miR‐469 Pachytene spermatocytes and round spermatids Liu et al. (2015) Regulates the chromatin remodeling
miR‐18 Expression at high levels in spermatocytes Saito et al. (2015) Maturation of male germ cells
miR‐122a In late stage male germ cells Wu et al. (2011) Remodeling of chromatin
miR‐355 Upregulation in testis of adult mouse Ito et al. (2010) Regulation at transcriptional level
miR‐181b Upregulation in adult testis Ito et al. (2010) Transcriptional regulation
miR‐181c Upregulation in adult testis Saito et al. (2015) Transcriptional regulation
miR‐185 In pachytene spermatocytes Liu et al. (2013) Cell cycle regulator
miR‐191 In beta pachytene spermatocytes Liu et al. (2013) Required for normal sperm morphology
Downregulated in teratozoospermia
miR‐10a Enriched in the spermatogonial cell population compared
with somatic cells of Day 6 testis
Foley et al. (2011),
Niu et al. (2011)
Cellular differentiation
miR‐124a Upregulated in mature rhesus monkey testis, ESCs Hunt et al. (2011),
Ryul Lee et al. (2010)
Suppression of cell migration,
pluripotency
miR‐125a Later male PGCs Zhong et al. (2010) Control of differentiation
miR‐21 Spermatogonial stem cells Zheng et al. (2011) Spermatogonial self‐renewal,
antiapoptosis, oncogene
miR‐509‐3 Expressed in human testis McIver et al. (2012)
Note. ESCs: embryonic stem cells; miR: microRN; PGCs: primordial germ cells; SSC: spermatogonial stem cell.
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same cluster, such as miR‐293 and miR‐292‐3p. Interestingly, the
promoter of these miRNAs is the location where c‐Myc binds,
suggesting that their operation is in downstream of c‐Myc. c‐Myc
demonstrated to have a predominant role in suppression of miR‐29a
and miR‐21 at the level of transcription. Both of these miRNAs have
been shown to act as p53 expression inhibitor, the role of which in
modulating iPSC reprogramming is well‐known (Banito et al., 2009;
Hong et al., 2009). The role of p53 pathway, which is known to
suppress tumor development, as a roadblock for iPSCs generation,
has been recently reported (Lin, Choi, Hicks, & He, 2012).
Although protein‐coding genes are considered as the main
targets of p53, several miRNAs have been reported vital in the
pathway of p53, which has opened an new area for researchers to
explore their role during cell programming. Three miRNAs of
miR‐199a, miR‐145, and miR‐145 are induced by p53, all of which
have been demonstrated to inhibit the generation of iPSCs via
different mechanism (Jain et al., 2012; Wang et al., 2012).
Conversely, p53 is directly targeted by miR‐138 and p21, a well‐
known component of the p53 pathway, which is targeted by
several miRNAs, such as miR‐290, miR‐106a/b and miR‐93, all of
which are able to promote iPSC generation (Gingold et al., 2014;
Luginbühl et al., 2017).
While the miR‐290 cluster was chosen based on its expression
during ESCs differentiation, other miRNAs have been candidates in
another study based on their role in the upregulation of iPSC
reprogramming, in its early stages in particular (Li, Yang,
Nakashima, & Rana, 2011). The generation of iPSCs is greatly
enhanced by the overexpression of miR‐93 and miR‐106b, two
members of the miR‐106a, while the efficiency of reprogramming
decreases by the knockdown of the same miRNAs as well as miR‐
25, another member of the same cluster, using miR‐inhibitors.
Certainly, the formation of iPSCs is not improved necessarily by
the factors essential for self‐renewal, but some barriers might
even be presented by these factors for cell reprogramming
(Luginbühl et al., 2017).
It has been shown that the efficiency of iPSCs reprogramming is
enhanced by several miRNAs when they are expressed along with a
few Yamanaka factors (Subramanyam et al., 2011). For example, the
cluster of miR‐17–92 can regulate MYC, and there can be an increase
in the levels of miR‐92 by MYC overexpression (Jia et al., 2013;
Wilson et al., 2010).
Regardless of the reprogrammed cells, pluripotent cells possess
two distinct categories of miRNA patterns derived from embryonic
or somatic cells (Neveu et al., 2010). Some families of miRNA,
including miR‐34, miR‐29a and miR‐21, interfere with the repro-
gramming process to enhance the iPSCs generation (C.‐S. Yang, Li, &
Rana, 2011). Inhibition of these miRNAs is associated with increased
efficiency of reprogramming. For example, genetic ablation of miR‐
34a by MEFs has enhanced the efficiency of reprogramming,
suggesting that miR‐34a can interfere with reprogramming. The
cluster of miR‐34 consists of three miRNAs: miR‐34a, miR‐34b, and
miR‐34c. Reprogramming of somatic cells is promoted by knockout of
miR‐34a or miR‐34a/b while it has been demonstrated that the
ablation of miR‐34a has a stronger effect on the generation of iPSCs,
compared to miR‐34b and miR‐34c (Luningschror et al., 2013). The
cluster of miR‐34 seems to act as a repressor for the target genes of
F IGURE 4 Regulatory networks of microRNAs (miRs) able to control the differentiation and self‐renewal of embryonic stem cells (ESCs) and
induced pluripotent stem cells (iPSCs). Model for the various roles of several different miRNA families in the gene regulatory network which
maintains differentiating and pluripotent cell states. Maintenance of ESCs and iPSc fate depends on the activity of the specific cell cycle
regulating (ESCC) miRNAs of ESC and iPSc, which are induced by the core pluripotency factors including Nanog, OCT4, KLF4, SOX2, LIN28, and
MYC [Color figure can be viewed at wileyonlinelibrary.com]
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p53. Among these targets, N‐Myc, Sox2, and Nanog were found to be
post‐transcriptionally regulated by the cluster of miR‐34 during
iPSCs induction (Choi et al., 2011; Figure 4).
6 | CONCLUSION
The roles of miRNAs in self‐renewal and differentiation of iPSCs and
ESCs are increasingly evident. In addition, their function in stem cells
is rapidly being discovered. Thanks to the introduction of new
technologies, such as deep‐sequencing and robust tools, for the
isolation of stem cells, it is projected that further studies will reveal
more miRNAs and their functions in diverse stem cell systems, as well
as their differentiated progeny from various human tissues.
However, to discover the increasingly diverse characteristics of
miRNA, more studies are required, including a deeper mechanistic
exploration into structure, localization and interacting partners, to
interpret their involvement in cell programming.
According to the results of the study, the ability of fine‐tuning the
levels of various factors in miRNA makes it capable of directing the
fate of stem cells. Regenerative medicine includes a practical strategy
known as manipulation of the miRNA level in stem cells ex vivo. To
perform hepatitis C‐related human clinical trials and nonhuman
primate preclinical trials, researchers have tested some of the most
developed anti‐miR therapies (e.g., micro‐RNA modulation) to assess
their efficiency. There are two possible categories of the miRNA
therapy, including miRNA inhibition and replacement therapies with
the ability of downregulating and upregulating the expression of the
miRNA, respectively. However, this classification depends of the
expression status of the target miRNA. In regenerative medicine,
some of the therapeutic impacts of miRNA include angiogenesis,
wound healing, cardiac regeneration, neurogenesis, bone regenera-
tion, and skeletal muscle.
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